EPID-17. ANALYSIS OF THE USE OF BEVACIZUMAB FOR THE TREATMENT OF GLIOBLASTOMA IN THE UNITED STATES

INTRODUCTION: Bevacizumab is an antibody against vascular endothelial growth factor that has been well investigated for glioblastoma, however, has limited proven efficacy. The drug has, however, demonstrated survival benefit in non-small cell lung carcinoma, renal cell carcinoma and colorectal carci...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neuro Oncol
Main Authors: Garcia, Catherine, Chitwood, Holly, Harwood, Christopher, Shelton, Brent, Morgan, Rachael, Vermuelen, Lee, Villano, John
格式: Artigo
語言:Inglês
出版: Oxford University Press 2019
主題:
Epidemiology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847562/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.317
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍